Pathogenic virus in gastrointestinal tract

"Pathogenic viruses in the gastrointestinal tract" is not a single molecular entity or therapeutic target but rather an umbrella term referring to various viruses capable of infecting and causing disease within the human digestive system. The most common pathogenic GI viruses include norovirus, rotavirus, adenovirus, and less frequently enteroviruses such as echoviruses and polioviruses[3][6]. These agents are responsible for acute gastroenteritis—characterized by diarrhea, vomiting, abdominal pain—and can be particularly severe in children, elderly individuals, and immunocompromised patients[5][6]. Each major GI virus has its own unique structure and host cell entry mechanism. For example: - Noroviruses are non-enveloped RNA viruses from the Caliciviridae family that primarily infect enterocytes via binding to histo-blood group antigens[1]. - Rotaviruses are double-stranded RNA Reoviridae that infect mature enterocytes using VP4/VP7 proteins. - Adenoviruses use fiber proteins to attach to cellular receptors on gut epithelial cells. Some emerging pathogens like SARS-CoV‑2 have also been shown to infect intestinal cells via ACE2 receptors highly expressed on small intestine epithelium[4]. Because "pathogenic viruses in the gastrointestinal tract" refers collectively to many different species with diverse biology—rather than one protein/receptor—it does not meet criteria for being considered a canonical drug target. Instead, each individual viral protein involved in host cell entry or replication may serve as an actual therapeutic target. Thus this term should be considered too broad/unspecific for structured drug-target databases. Key points: - The main causative agents differ by age: rotavirus predominates in children while norovirus causes most adult cases[6]. - Diagnosis relies on detection of viral nucleic acids or antigens from stool samples using RT-qPCR or EIA assays depending on the pathogen[1]. - There are no broad-spectrum antivirals targeting all GI pathogenic viruses; vaccines exist only for some (e.g., rotavirus)[3]. - Pathogenesis involves direct infection/destruction of gut epithelial cells leading to fluid loss and inflammation. - Some host factors like FcRn receptor mediate susceptibility specifically for certain enteroviruses such as echovirus[2], while others like ACE2 facilitate SARS-CoV‑2 entry into gut tissue[4]. In summary: "Pathogenic virus in gastrointestinal tract" is not itself an actionable molecular drug target but rather describes a clinically important category encompassing multiple distinct viral pathogens with varying mechanisms relevant for infectious disease management.

Other names

Gastrointestinal virusEnteric virusGI tract pathogenic virusViral agent of gastroenteritis